Defective Drug Lawyers: TrasylolDid you develop kidney damage or have a heart attack or stroke after undergoing heart surgery? You may be the victim of the defective drug Trasylol, made by Bayer AG. Trasylol is a drug commonly used to prevent excessive bleeding in patients undergoing coronary artery bypass graft (CABG) surgery. This medication has been found to greatly increase the risk of kidney failure, heart attack and stroke. Because Trasylol is administered during surgery, patients are unaware that they have been exposed to the drug's risks. Passionate Representation, Historic Results If you developed kidney or heart problems after bypass surgery, the attorneys of Hersh & Hersh may be able to help you recover financial compensation for the damages you suffered because of this dangerous and defective drug. Please contact us today to discuss your case. Since January 2006, the FDA has been conducting a safety review of Trasylol, a drug used to reduce blood loss and the need for blood transfusion during some types of heart surgeries. One study determined that receiving Trasylol increased patients' risk for death, kidney failure, congestive heart failure and stroke. Trasylol Found to Significantly Increase Risk
|


